Shaylee Yount in Immunotherapy - Cancer and Beyond 704 Collaborate2Cure:The Role of Complex Gut Microbiota in the Susceptibility to Colorectal Cancer, James M. Amos-Landgraf, PhDDecember 15, 2017
Shaylee Yount in Immunotherapy - Cancer and Beyond 735 Collaborate2Cure: Tolerance Induction for Organ Transplants by Myeloid Progenitor Cells, Jos Domen, PhDDecember 15, 2017
Shaylee Yount in Immunotherapy - Cancer and Beyond 785 Collaborate2Cure: Antigen-targeted Therapy for Head and Neck Cancer, Sufi Thomas, PhDCollaborate2Cure: October 20, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 7412 Collaborate2Cure:Quest for Developing Novel Immunological Assays for Cancer Immunotherapy, Francisco Martinez Becerra, PhDDecember 1, 2017
Shaylee Yount in Immunotherapy - Cancer and Beyond 711 Collaborate2Cure: Isolation and Molecular Profiling of Circulating Tumor Cells with Divergent Phenotypes, Maggie Witek, PhDDecember 1, 2017
Shaylee Yount in Immunotherapy - Cancer and Beyond 752 Collaborate2Cure: Translating Research into Clinical Practice in Hepatocellular Cancer, Kevin Staveley-O’Carroll, MD, PhD December 8, 2017
Shaylee Yount in Immunotherapy - Cancer and Beyond 776 Collaborate2Cure:Tumor In a Dish: Novel Approach for Personalized Medicine, Shrikant Anant, PhDDecember 8, 2017
Shaylee Yount in Immunotherapy - Cancer and Beyond 974 Collaborate2Cure: (2) Immune Monitoring Toolkit for Canine Immunotherapy Trials, Hans Rindt, PhD Sandra Bechtel, DVM, DACVIMNovember 17, 2016 (part 2)
Shaylee Yount in Immunotherapy - Cancer and Beyond 836 Collaborate2Cure: Immune Monitoring Toolkit for Canine Immunotherapy Trials, Jeffrey N. BryanNovember 17, 2016
Shaylee Yount in Immunotherapy - Cancer and Beyond 817 Collaborate2Cure: Immunotherapy of Osteosarcoma, Laura Simon Treml, VMD, PhDNovember 10, 2016